NNC0662-0419

DRUG6 trials

Sponsors

Novo Nordisk A/S

Conditions

Diabetes Mellitus, Type 2ObesityOverweight

Phase 1

A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity

CompletedNCT06737536

Novo Nordisk A/SObesity, Overweight

Start: 2024-12-18End: 2025-07-26Updated: 2025-09-19

A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity

CompletedNCT07101783

Novo Nordisk A/SObesity, Overweight

Start: 2025-08-01End: 2025-10-31Updated: 2025-12-23

A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight

RecruitingNCT07525791

Novo Nordisk A/SObesity, Overweight

Start: 2026-04-07End: 2027-05-04Target: 45Updated: 2026-04-24

Phase 2

A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity

Active, not recruitingNCT07184632

Novo Nordisk A/SObesity, Overweight

Start: 2025-10-01End: 2026-12-14Updated: 2026-05-07

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

RecruitingNCT07415954

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2026-04-17End: 2027-10-01Target: 270Updated: 2026-06-30

A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

RecruitingNCT07639021

Novo Nordisk A/SObesity

Start: 2026-06-09End: 2027-07-12Target: 230Updated: 2026-07-10